Englyn 5 mg Tablet 10's Substitute

Englyn 5 mg Tablet 10's contains Linagliptin, which belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors used Englyn 5 mg Tablet 10's is prescribed for the condition of type 2 diabetes when diet and exercise alone cannot control their blood sugar levels. It works by blocking the action of DPP-4 (an enzyme that destroys the hormone ‘Incretin’). The enzyme ‘Incretins’ helps produce more insulin only when required and reduces the liver's blood sugar level when not needed. Englyn 5 mg Tablet 10's should not be used in patients with type 1 diabetes and for the treatment of diabetic ketoacidosis.

Type 2 diabetes is a common form of diabetes. The body cannot make a sufficient amount of insulin and the body's insulin does not function properly. The blood glucose level increases, and symptoms such as frequent urination, increased thirst, and increased hunger . Diabetes, if left untreated or not treated properly, can cause long-term complications like nerve damage, kidney damage, eye damage, foot problems, and fall under a higher risk of developing heart diseases.

Hypoglycemia refers to low blood sugar levels. Englyn 5 mg Tablet 10's can cause hypoglycemia. The symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness. Hypoglycemia can occur if you miss or delay your food, drink alcohol, over-exercise or take other antidiabetic medicine along with this medicine. People with diabetes are advised to keep a quick sugar source like glucose tablets, honey or fruit juice.

Englyn 5 mg Tablet 10's should be avoided in patients who are allergic to any of this medicine's components or excipients. It should be avoided in patients suffering from moderate to severe kidney disease and in patients with underlying metabolic acidosis, including diabetic ketoacidosis, consult your doctor for further advice.

No. Englyn 5 mg Tablet 10's is only prescribed to treat type 2 diabetes, also called 'non-insulin-dependent diabetes.'